SMTL ID : 4ov6.1 (1 other biounit)

Crystal structure of PCSK9(53-451) with Adnectin

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.69 Å

Oligo State

hetero-1-1-1-mer

Ligands

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 5 residues within 4Å: Chain A: W.13, F.91 Chain B: K.106 Chain C: Y.80, H.82 2 PLIP interactions: 1 interactions with chain B, 1 interactions with chain C Hydrogen bonds: B:K.106, C:H.82 EDO.2: 4 residues within 4Å: Chain B: F.166, R.167, D.168, L.199 No protein-ligand interaction detected (PLIP) EDO.3: 3 residues within 4Å: Chain B: P.3, D.86, F.227 No protein-ligand interaction detected (PLIP)

1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.4: 3 residues within 4Å: Chain B: Q.261, I.264, L.288 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:Q.261, B:Q.261 Water bridges: B:R.260

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mitchell, T. et al., Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering. J.Pharmacol.Exp.Ther. (2014)

Release Date

2014-07-02

Peptides

Proprotein convertase subtilisin/kexin type 9: A
Proprotein convertase subtilisin/kexin type 9: B
Adnectin: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
F

Proprotein convertase subtilisin/kexin type 9

Proprotein convertase subtilisin/kexin type 9

Adnectin

Related Entries With Identical Sequence